Z-SYMBOLS

With sell of Apple tomorrow I’ll start to unwind my end of the year rally buys

With sell of Apple tomorrow I’ll start to unwind my end of the year rally buys

When I bought shares of Apple (AAPL) in my Jubak Picks and Volatility Portfolios, I was looking for gains from the end of the year rally (which kind of fizzed out) and the traditional Santa Claus rally (which came through as expected) to drive shares higher in the short term. Since that November 23, 2021 pick, shares of Apple, as of the close today January 4, were up 12% to $179.70, just above my $179 target price for this short-term trade.

Should you invest in China now? Attacking the puzzle with buys on Monday of TCEHY and FXI

Should you invest in China now? Attacking the puzzle with buys on Monday of TCEHY and FXI

In other years this would clearly be the time to jump into China stocks. What we have right now is a classic, tried-and-true set up for big gains from buying China stocks. With a “but” or two that suggests a cautious strategy. But I will be buying shares of Tencent Holdings and the FXI ETF on Monday, January 3.

Li-Cycle Holdings gets pounded today on really good news

Li-Cycle Holdings gets pounded today on really good news

Li-Cycle Holdings LICY), a recycler of rechargeable lithium-ion batteries, has entered into a non-binding letter of intent to supply LG Chem, Korea’s largest diversified chemical company and LG Energy Solution, a leader in the market for lithium-ion batteries for electric vehicles, with 20,000 metric tons of nickel from recycled waters over the 10 year beginning in 2023. Upon signing of the final agreement, LG Chem and LG Energy Solutions will together make a $50 million buy of shares in Li-Cycle.

CVS Health raises dividend and 2022 revenue guidance

CVS Health raises dividend and 2022 revenue guidance

CVS Health (CVS) will raise its annual dividend by 10% to $2.20 from $2.00 effective with the dividend payout scheduled for February 1. The company has also authorized a $10 billion share buyback program. The company also raised guidance for the full 2021 year to revenue of at least $290.3 billion and earnings of at least $8.00 a share.

3 shots good; 4 shots better

3 shots good; 4 shots better

Executives at Pfizer (PFE), which, remember, makes a Corona-19 vaccine–said yesterday, December 8, that the new Omicron Variant could increase the likelihood that people will need a fourth coronavirus vaccine dose earlier than expected.